We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+11.83%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
–
AUM
$384M
AUM Growth
+$42.1M
Cap. Flow
+$6.1M
Cap. Flow %
1.59%
Top 10 Hldgs %
33.42%
Holding
402
New
39
Increased
71
Reduced
55
Closed
20

Top Buys

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$3.64M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.27M
3
GILD icon
Gilead Sciences
GILD
+$1.9M
4
SBCF icon
Seacoast Banking Corp of Florida
SBCF
+$1.75M
5
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$1.53M

Top Sells

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$1.7M
2
NVDA icon
NVIDIA
NVDA
+$477K
3
ET icon
Energy Transfer Partners
ET
+$408K
4
IBM icon
IBM
IBM
+$398K
5
MCD icon
McDonald's
MCD
+$344K

Sector Composition

Rank Sector Weight
1 Technology 25.59%
2 Healthcare 14.79%
3 Consumer Staples 13.71%
4 Miscellaneous 12.81%
5 Financials 12.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCL icon
301
Carnival Corporation Ltd
CCL
$33.9B
$6K ﹤0.01%
300
– –
HP icon
302
Helmerich & Payne
HP
$4.25B
$6K ﹤0.01%
250
– –
LOW icon
303
Lowe's Companies
LOW
$117B
$6K ﹤0.01%
40
– –
NFLX icon
304
Netflix
NFLX
$340B
$6K ﹤0.01%
120
– –
O icon
305
Realty Income
O
$58.6B
$6K ﹤0.01%
103
– –
PCRX icon
306
Pacira BioSciences
PCRX
$1.03B
$6K ﹤0.01%
104
– –
SNY icon
307
Sanofi
SNY
$107B
$6K ﹤0.01%
+131
New +$6.46K
JJC
308
DELISTED
iPath Bloomberg Copper Subindex Total Return ETN due October 22, 2037
JJC
$6K ﹤0.01%
+150
New +$6K
ACAD icon
309
Acadia Pharmaceuticals
ACAD
$5.02B
$5K ﹤0.01%
100
– –
CNI icon
310
Canadian National Railway
CNI
$76.2B
$5K ﹤0.01%
50
– –
DAL icon
311
Delta Air Lines
DAL
$52.7B
$5K ﹤0.01%
+120
New +$4.36K
DPZ icon
312
Domino's
DPZ
$11.6B
$5K ﹤0.01%
12
– –
EBAY icon
313
eBay
EBAY
$47B
$5K ﹤0.01%
100
– –
ISRG icon
314
Intuitive Surgical
ISRG
$132B
$5K ﹤0.01%
18
– –
IWN icon
315
iShares Russell 2000 Value ETF
IWN
$14.5B
$5K ﹤0.01%
40
-40
-50% -$4.72K
J icon
316
Jacobs Solutions
J
$17.8B
$5K ﹤0.01%
60
– –
KR icon
317
Kroger
KR
$35.4B
$5K ﹤0.01%
152
+1
+0.7% +$32
LYFT icon
318
Lyft
LYFT
$6.7B
$5K ﹤0.01%
100
– –
MFC icon
319
Manulife Financial
MFC
$70.9B
$5K ﹤0.01%
268
– –
MUSA icon
320
Murphy USA
MUSA
$9.25B
$5K ﹤0.01%
35
– –
CI icon
321
Cigna
CI
$73.7B
$4K ﹤0.01%
18
-199
-92% -$39K
CMRE icon
322
Costamare
CMRE
$1.86B
$4K ﹤0.01%
500
– –
GDX icon
323
VanEck Gold Miners ETF
GDX
$31B
$4K ﹤0.01%
100
– –
GSG icon
324
iShares S&P GSCI Commodity-Indexed Trust
GSG
$967M
$4K ﹤0.01%
300
– –
HACK icon
325
Amplify Cybersecurity ETF
HACK
$2.97B
$4K ﹤0.01%
63
– –
11 12
13
14 15

Similar funds

BPM
Bowling Portfolio Management Cincinnati, Ohio $364M AUM 7.07% 1-Year Est. Return
S
Surevest Los Angeles, California $368M AUM 13.7% 1-Year Est. Return
ACM
Axar Capital Management New York $304M AUM 38.78% 1-Year Est. Return
GMA
Goldstein Munger & Associates San Ramon, California $303M AUM 19.66% 1-Year Est. Return
AW
ACG Wealth Atlanta, Georgia $437M AUM 11.28% 1-Year Est. Return
RFA
Radnor Financial Advisors Wayne, Pennsylvania $284M AUM 23.21% 1-Year Est. Return
AIA
AGF Investments America Toronto, Ontario, Canada $271M AUM 7.04% 1-Year Est. Return
SMG
Spectrum Management Group Indianapolis, Indiana $460M AUM 10.37% 1-Year Est. Return

American Research & Management Company's Q4 2020 Portfolio in Review

As of Q4 2020, American Research & Management Company held 402 positions worth $384M, up 12% from $342M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

American Research & Management Company's Q4 2020 filing shows 39 new, 71 increased, 55 reduced and 20 closed positions. Its largest new stake was Vertex Pharmaceuticals: 9,888 shares worth $2.34M. The largest sale was iShares Gold Trust, an estimated $1.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Staples.

  • American Research & Management Company's largest Q4 2020 buy was Vertex Pharmaceuticals: 9,888 shares worth $2.34M.
  • American Research & Management Company added most to Franco-Nevada in Q4 2020, an estimated $3.64M increase.
  • American Research & Management Company's biggest Q4 2020 reduction was iShares Gold Trust, cutting an estimated $1.7M.
  • American Research & Management Company fully exited iShares Russell Mid-Cap Growth ETF in Q4 2020, selling an estimated $25K.
  • American Research & Management Company's ten largest holdings make up 33% of its $384M portfolio in Q4 2020.
  • American Research & Management Company opened 39 new positions and closed 20 in Q4 2020.
  • American Research & Management Company's portfolio value rose 12% quarter-over-quarter to $384M.

Based on American Research & Management Company's 13F filing for Q4 2020, filed 28 Jan 2021.